Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (8): 739-741.DOI: 10.3969/j.issn.1673-8640.2019.08.014
Previous Articles Next Articles
Received:
2018-10-18
Online:
2019-08-30
Published:
2019-08-27
CLC Number:
. [J]. Laboratory Medicine, 2019, 34(8): 739-741.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.08.014
疾病 | 例数 | 性别 | IgG型 | IgA型 | FL型 | IgM型 | IgD型 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | |||||||
MM | 112 | 78 | 34 | 25 | 17 | 18 | 17 | 14 | 15 | 1 | 0 | 2 | 3 | |||||
MGUS | 54 | 36 | 18 | 12 | 14 | 4 | 9 | 6 | 0 | 6 | 3 | 0 | 0 | |||||
POEMS综合征 | 16 | 11 | 5 | 0 | 2 | 4 | 9 | 0 | 0 | 1 | 0 | 0 | 0 | |||||
浆细胞瘤/浆细胞白血病 | 8 | 5 | 3 | 0 | 4 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | |||||
淀粉样变性 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
华氏巨球蛋白血症 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |||||
淋巴瘤/单克隆B淋巴细胞增殖性疾病 | 10 | 6 | 4 | 0 | 1 | 1 | 0 | 0 | 0 | 6 | 2 | 0 | 0 | |||||
慢性淋巴细胞白血病 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
原发性骨髓纤维化 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
幼淋巴细胞性白血病 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
慢性炎症性脱髓鞘性多发性神经病 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
尿胞内分枝杆菌感染(体液免疫缺陷) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
疾病 | 例数 | 性别 | IgG型 | IgA型 | FL型 | IgM型 | IgD型 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
男 | 女 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | κ型 | λ型 | |||||||
MM | 112 | 78 | 34 | 25 | 17 | 18 | 17 | 14 | 15 | 1 | 0 | 2 | 3 | |||||
MGUS | 54 | 36 | 18 | 12 | 14 | 4 | 9 | 6 | 0 | 6 | 3 | 0 | 0 | |||||
POEMS综合征 | 16 | 11 | 5 | 0 | 2 | 4 | 9 | 0 | 0 | 1 | 0 | 0 | 0 | |||||
浆细胞瘤/浆细胞白血病 | 8 | 5 | 3 | 0 | 4 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | |||||
淀粉样变性 | 3 | 2 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
华氏巨球蛋白血症 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |||||
淋巴瘤/单克隆B淋巴细胞增殖性疾病 | 10 | 6 | 4 | 0 | 1 | 1 | 0 | 0 | 0 | 6 | 2 | 0 | 0 | |||||
慢性淋巴细胞白血病 | 2 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
原发性骨髓纤维化 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |||||
幼淋巴细胞性白血病 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
慢性炎症性脱髓鞘性多发性神经病 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
尿胞内分枝杆菌感染(体液免疫缺陷) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
[1] | DISPENZIERI A.POEMS syndrome:2017 update on diagnosis,risk stratification,and management[J]. Am J Hematol,2017,92(8):814-829. |
[2] | BERGóN E,MIRAVALLES E. Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district:14-year series[J]. Clin Chem Lab Med,2007,45(2):190-196. |
[3] | BARLOGIE B,EPSTEIN J,SELVANYAGAM P,et al.Plasma cell myeloma-new biological insights and advances in therapy[J]. Blood,1989,73(4):865-879. |
[4] | WANG H,GAO C,XU L,et al.Laboratory characterizations on 2007 cases of monoclonal gammopathies in east China[J]. Cell Mol Immunol,2008,5(4):293-298. |
[5] | 赵磊,徐双,裴林,等. IgM型单克隆免疫球蛋白阳性107例临床特征分析[J]. 中国实用内科杂志,2016, 36(2):137-140. |
[6] | 陈美兰,李娟,刘俊茹,等. IgD型多发性骨髓瘤18例临床特征和生存分析[J]. 中国实用内科杂志,2011,31(11):868-870. |
[7] | WILLRICH M A,KATZMANN J A.Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias[J]. Clin Chem Lab Med,2016, 54(6):907-919. |
[8] | 汪薇. 多发性骨髓瘤实验室检查特点[J]. 检验医学,2015,30(8):847-851. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||